• Prof Andrew Hanby, Professor of Breast Pathology, Leeds
  • Dr Abeer Shaaban, Consultant Breast Pathologist, Leeds
  • Dr Sally Lane, Consultant Breast Pathologist, Leeds
  • Dr Colin Purdie, Consultant Pathologist, Dundee
  • Dr Nisha Sharma, Consultant Radiologist, Leeds
  • Dr Barbara Dall, Consultant Radiologist, Leeds
  • Dr Julian Adlard, Consultant Clinical Oncologist, Leeds
  • Dr Philip Turton, Consultant Oncoplastic Breast Surgeon

downloaddownload (1)
Dr Julian Adlard is consultant and honorary senior lecturer in the departments of Clinical Oncology and Genetics in Leeds. He trained in Newcastle and Leeds and has special interests in non-surgical breast cancer management and the genetics of hereditary cancer syndromes. He is Vice Chairman of the Yorkshire Cancer Network Breast NSSG, member of the UK Sloane Project Steering group, and Treasurer of the steering committee of the UK Cancer Genetics Group.
Dr Dall trained in Glasgow and then moved to Leeds in 1992. She was involved with the set up of one of the earliest breast MRI clinical services in the UK in Leeds in 1998 and then the MRI biopsy service in 2002. She was appointed by the Royal College of Radiology Breast Group as the 2009 Breast Imaging Group Visiting Professor.
Dr Lane worked in general and specialist breast histology and cytology as a consultant and continues to support the structured approach to diagnostic work initiated by the comprehensive NHS Breast Screening programme. This approach helped the consistent introduction of the sentinel node biopsy as an MD team-based system and Dr Lane has been closely associated with this, lecturing on the Leeds unit arm of the New Start programme.

Dr Shaaban is a Consultant Breast Pathologist/ Honorary Senior Lecturer Department of Histopathology and Molecular Pathology, St James’s University Hospital. Dr Shaaban is a specialist breast pathologist who works in a large tertiary referral centre and a regional centre for HER2 immunohistochemistry and FISH testing.
Dr Shaaban did a PhD on the analysis of morphological and molecular markers associated with breast neoplasia progression and published with the late Professor JP Sloane, one of the pioneers in the field of breast pathology. Her areas of interest include diagnostic and prognostic markers in breast cancer, in particular estrogen receptors, columnar cell lesions and male breast cancer. She produced many research articles, reviews and book chapters. Dr Shaaban is member of the NCRI Breast Clinical Studies Group and The NCRI Breast CSG Translational Subgroup.

Dr Sharma was born in Glasgow and did the first half of her radiology training in Glasgow and then moved to Leeds to complete her training. In 2007 Dr Sharma took up a consultant job in Bradford as a Radiologist with a specialist interest in Breast. In October 2008 she was appointed as Director of breast screening for Leeds/Wakefield.
Dr Turton has Full Registration on the GMC Specialist Register (GMC number 3613582) and holds a Substantive post as a Consultant Breast and Reconstructive Breast Surgeon at the Leeds Teaching Hospitals Trust, based at Leeds General Infirmary, Leeds, UK. Dr Turton is also an Honorary Senior Lecturer in Surgery for the Leeds Teaching Hospitals Trust. He teaches medical students and junior doctors about the basic principles of surgery and the specialist area of breast surgery. He is also a surgical trainer for Specialist Registrars learning the intricacies of Cosmetic Breast Surgery, Reconstructive Breast Surgery and Oncoplastic Breast Surgery. He is a member of the Education and Training Committee of the Association of Breast Surgery at BASO.
Professor Andrew Hanby is Professor of Breast Pathology and consultant histopathologist at St James’s University Hospital in Leeds. He has been involved in breast cancer research since 1989, including self driven indigenous research, extensive collaborative research and the IBIS-1 trial. His particular expertise is in tissue banking, issues related to consent and the production of tissue micro-arrays (TMAs). He maintains a diagnostic workload and is lead for the regional HER2 testing service.